We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current ALBIO market cap is 45.14M. The company's latest EPS is EUR 1.4509 and P/E is 2.89.
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 31.43M | 36.13M | 168.64M | 382.53M | 206.53M |
| Operating Income | 720k | 1.6M | 51.75M | 144.36M | 38.88M |
| Net Income | 542k | 1.1M | 31.37M | 104M | 15.61M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 39.46M | 47M | 126.07M | 268.94M | 260.34M |
| Total Liabilities | 10.2M | 16.48M | 59.79M | 101.14M | 93.44M |
| Total Equity | 29.26M | 30.52M | 66.29M | 167.81M | 166.9M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | N/A | N/A | 31.64M | 109.83M | 4.95M |
| Investing | N/A | N/A | -7.93M | -28.96M | -39.08M |
| Financing | N/A | N/A | 10.62M | 14.4M | -10.81M |
| Market Cap | 45.14M |
| Price to Earnings Ratio | 2.89 |
| Price to Sales Ratio | 0.22 |
| Price to Cash Ratio | 0.52 |
| Price to Book Ratio | 0.27 |
| Dividend Yield | - |
| Shares Outstanding | 10.76M |
| Average Volume (1 week) | 6.72k |
| Average Volume (1 Month) | 12.7k |
| 52 Week Change | -42.14% |
| 52 Week High | 11.00 |
| 52 Week Low | 3.915 |
| Spread (Intraday) | 0.04 (0.95%) |
| Company Name | Biosynex |
| Address |
22 boulevard sebastien brant illkirch-graffenstaden, bas-rhin 67400 |
| Website | https://www.biosynex.com |
| Industry | offices of medical doctors (8011) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
